Outcomes measures in idiopathic intracranial hypertension

Research output: Contribution to journalArticlepeer-review

Authors

Colleges, School and Institutes

Abstract

Introduction

Idiopathic Intracranial Hypertension is condition characterised by raised intracranial pressure, papilledema, and normal neuroimaging (aside from radiological signs of raised intracranial pressure). Symptoms of idiopathic intracranial hypertension include chronic headaches and for some, visual loss. New treatments are an unmet clinical need.

Areas covered

The aim of this review is to present the evidence base and considered opinion on outcome measures to determine successful management of idiopathic intracranial hypertension.

Expert opinion

Less invasive measures of disease activity such as optical coherence tomography will continue to grow in this field, both as a measure of papilledema, and potentially as a surrogate for intracranial pressure and visual function. As a highly disabling aspect of the disease is headache, treatment outcomes for headache morbidity need to be appropriately chosen and standardized to allow comparison between trials.

Details

Original languageEnglish
JournalExpert Review of Neurotherapeutics
Early online date28 May 2021
Publication statusE-pub ahead of print - 28 May 2021